Showing results (51-60 of 965) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|May 17, 2019
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceFilipe Martins, Latifyan Sofiya, Gerasimos P Sykiotis, et al.Nature Reviews. Clinical Oncology|April 25, 2018
The multiple myelomas - current concepts in cytogenetic classification and therapyShaji K Kumar, S Vincent RajkumarNature Reviews. Clinical Oncology|May 20, 2018
Evolution of CLL treatment - from chemoimmunotherapy to targeted and individualized therapyJan A Burger, Susan O'BrienNature Reviews. Clinical Oncology|April 26, 2022
Optimal systemic therapy for high-risk resectable melanomaAlexander M M Eggermont, Omid Hamid, Georgia V Long, et al.Nature Reviews. Clinical Oncology|February 8, 2022
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeuticsHirohito Yamaguchi, Jung-Mao Hsu, Wen-Hao Yang, et al.Nature Reviews. Clinical Oncology|April 28, 2011
Clinical implications of cancer self-seedingElizabeth Comen, Larry Norton, Joan MassaguéNature Reviews. Clinical Oncology|August 1, 2009
Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancerFleur Huang, Yael B Kushner, Adrian Langleben, et al.Nature Reviews. Clinical Oncology|May 19, 2010
A case of variant angina in a patient under chronic treatment with sorafenibItalo Porto, Andrea Leo, Luca Miele, et al.Nature Reviews. Clinical Oncology|May 5, 2010
Treatment of localized prostate cancer: when is active surveillance appropriate?Peter C AlbertsenNature Reviews. Clinical Oncology|June 2, 2009
Medical oncology: Multimodality therapy in unresectable colorectal cancerDaniel A Popowich, Amy L HalversonPageof 97